Back
MoonLake Immunotherapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
37
MLTX
MoonLake Immunotherapeutics
Last Price:
46.48
Seasonality Move:
18.28%
Buy
70
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
37
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $46.40. The Score for MLTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- MLTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $331.32. The Score for MDGL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $46.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $331.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 42.39 | Sell |
| Chaikin Money Flow: | 9720 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.62 - 51.08) | Sell |
| Bollinger Bands (100): | (42.76 - 50.42) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.42 | Buy |
| Relative Strength Index (14 RSI): | 86.69 | Buy |
| Chaikin Money Flow: | 576514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.5 - 254.66) | Buy |
| Bollinger Bands (100): | (221.16 - 280.26) | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.97 | Sell |
| 20-day SMA: | 47.99 | Sell |
| 50-day SMA: | 49.15 | Sell |
| 200-day SMA: | 47.31 | Sell |
| 8-day EMA: | 47.05 | Sell |
| 20-day EMA: | 47.99 | Sell |
| 50-day EMA: | 48.28 | Sell |
| 200-day EMA: | 46.78 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 246.83 | Buy |
| 20-day SMA: | 225.95 | Buy |
| 50-day SMA: | 229.96 | Buy |
| 200-day SMA: | 241.65 | Buy |
| 8-day EMA: | 263.88 | Buy |
| 20-day EMA: | 237.89 | Buy |
| 50-day EMA: | 234.01 | Buy |
| 200-day EMA: | 235.45 | Buy |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.76 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
MoonLake Immunotherapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||